News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,420 Results
Type
Article (41090)
Company Profile (268)
Press Release (680052)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204673)
Career Advice (2024)
Deals (35531)
Drug Delivery (110)
Drug Development (81389)
Employer Resources (173)
FDA (16402)
Job Trends (14943)
News (346407)
Policy (32748)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49584)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16667)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (175)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4750)
Cardiovascular disease (395)
Career advice (1708)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (729)
Cervical cancer (36)
Clinical research (69494)
Collaboration (1666)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2707)
CRISPR (88)
C-suite (810)
Cystic fibrosis (143)
Data (6144)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6670)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90038)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117185)
Executive appointments (958)
FDA (19475)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1444)
Gene editing (192)
Generative AI (42)
Gene therapy (582)
GLP-1 (962)
Government (4653)
Grass and pollen (6)
Guidances (383)
Healthcare (18869)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2965)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (316)
IPO (16638)
IRA (49)
Job creations (3642)
Job search strategy (1428)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7954)
Liver cancer (91)
Longevity (14)
Lung cancer (638)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (777)
MASH (161)
Medical device (13753)
Medtech (13805)
Mergers & acquisitions (19950)
Metabolic disorders (1250)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2864)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4508)
Now hiring (65)
Obesity (586)
Opinion (256)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (470)
Peanut (55)
People (58810)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21666)
Phase 2 (30587)
Phase 3 (22790)
Pipeline (5071)
Policy (278)
Postmarket research (2564)
Preclinical (9200)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (813)
Real estate (5953)
Recruiting (69)
Regulatory (24428)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Last 7 days (591)
Last 30 days (2085)
Last 365 days (29734)
2026 (2811)
2025 (30178)
2024 (35218)
2023 (40076)
2022 (51178)
2021 (55714)
2020 (54086)
2019 (46549)
2018 (35023)
2017 (32114)
2016 (31497)
2015 (37567)
2014 (31332)
2013 (26368)
2012 (28588)
2011 (29283)
2010 (27347)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39201)
Australia (6410)
California (11153)
Canada (3251)
China (1082)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84498)
Florida (1660)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (850)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7988)
Michigan (319)
Minnesota (621)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2965)
New Mexico (28)
New York (2939)
North Carolina (1433)
North Dakota (8)
Northern California (5435)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4339)
Tennessee (172)
Texas (1718)
United States (39532)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,420 Results for "stemcells inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
November 11, 2025
·
3 min read
Deals
STEMCELL Technologies Announces Acquisition of Propagenix Inc.
STEMCELL Technologies is pleased to announce the acquisition of Propagenix Inc.
January 19, 2024
·
3 min read
Press Releases
Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer
August 21, 2025
·
2 min read
Press Releases
STEMCELL Technologies Announces Acquisition of Cellular Highways
June 2, 2025
·
3 min read
Press Releases
Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies
October 7, 2025
·
4 min read
Press Releases
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries
June 27, 2025
·
1 min read
Business
Applied StemCell, Inc. Strengthens Executive Leadership with Two Key Appointments
Applied StemCell, Inc. is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer).
December 4, 2023
·
3 min read
Press Releases
Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
June 25, 2025
·
2 min read
Press Releases
Applied StemCell Launches Two New Hypoimmunogenic hiPSC Products to Accelerate Allogeneic Cell Therapy Development
May 21, 2025
·
2 min read
Press Releases
Dr. Gail Humble - At The Genetic Frontier of Regenerative Skincare
With over two decades of pioneering work in upregulating the age-suppressing Klotho gene via stem-cell bioengineering, Dr. Humble brings rigorous science—and real results—to aesthetic medicine.
August 28, 2025
·
1 min read
1 of 72,142
Next
